Barbara McGowan

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 3.9K citations

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension

John Wilding, Rachel L. Batterham, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2022 · 766 citations · Full text

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan et al. · The Lancet · 2018 · 751 citations

Obesity, Non-pharmacological Intervention, Weight Loss +8

Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males

Waljit S. Dhillo, Owais B. Chaudhri, Michael Patterson et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 649 citations · Full text